The Economic Burden of Head and Neck Cancer: A Systematic Literature Review von Wissinger, Erika, Griebsch, Ingolf, Lungershausen, Juliane, Foster, Talia, Pashos, Chris L.

Volltext

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations von YANG, James Chih-Hsin, HIRSH, Vera, PALMER, Michael, SEQUIST, Lecia V, SCHULER, Martin, YAMAMOTO, Nobuyuki, O'BYRNE, Kenneth J, MOK, Tony S. K, ZAZULINA, Victoria, SHAHIDI, Mehdi, LUNGERSHAUSEN, Juliane, MASSEY, Dan

Volltext

Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting von Chouaid, Christos, Agulnik, Jason, Goker, Erdem, Herder, Gerarda J.M., Lester, Jason F., Vansteenkiste, Johann, Finnern, Henrik W., Lungershausen, Juliane, Eriksson, Jennifer, Kim, Kun, Mitchell, Paul L.R.

Volltext

Afatinib in the treatment of EGFR mutation-positive NSCLC – A network meta-analysis von Popat, Sanjay, Mok, Tony, Yang, James Chih-Hsin, Wu, Yi-Long, Lungershausen, Juliane, Stammberger, Uz, Griebsch, Ingolf, Fonseca, Tiago, Paz-Ares, Luis

Volltext

Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced... von Geater, Sarayut L, Xu, Chong-Rui, Zhou, Caicun, Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Li, Wei, Hou, Mei, Shi, Jian Hua, Lee, Kye Young, Palmer, Michael, Shi, Yang, Lungershausen, Juliane, Wu, Yi-Long

Volltext

The Humanistic Burden of Head and Neck Cancer: A Systematic Literature Review von Wissinger, Erika, Griebsch, Ingolf, Lungershausen, Juliane, Byrnes, Michael, Travers, Karin, Pashos, Chris L.

Volltext

Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Co... von Wu, Yi-Long, Hirsh, Vera, Sequist, Lecia V., Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Schuler, Martin, Mok, Tony, Yamamoto, Nobuyuki, O’Byrne, Kenneth, Geater, Sarayut L., Zhou, Caicun, Massey, Dan, Märten, Angela, Lungershausen, Juliane, Yang, James Chih-Hsin

Volltext

Development of a patient-reported outcome (PRO) measure for assessing non-small cell lung cancer (NSCLC) symptoms in clinical trials: Interim report from the PRO Consortium’s NSCLC... von Campbell, Alicyn K., Martin, Mona L., Arduino, Jean Marie, Atkinson, Thomas Michael, Lundy, J. Jason, Lungershausen, Juliane, Denis, Louis J., Liepa, Astra M.

Volltext

Afatinib (A) vs erlotinib (E) as second-line treatment of patients (pts) with advanced squamous cell carcinoma (SCC) of the lung following first-line platinum-based chemotherapy: P... von Gadgeel, Shirish M., Cobo Dols, Manuel, Felip, Enriqueta, Soria, Jean-Charles, Lee, Ki Hyeong, Lu, Shun, Georgoulias, Vassilis, Fulop, Andrea, Goker, Erdem, Syrigos, Konstantinos N., Morabito, Alessandro, Coskun, Hasan Senol, Guclu, Salih Zeki, Li, Wei, Popat, Sanjay, Ardizzoni, Andrea, Lungershausen, Juliane, Wang, Bushi, Chand, Vikram K., Goss, Glenwood D.

Volltext

Treatment and treatment outcomes of advanced NSCLC patients in routine clinical care: Results of the retrospective LUCEOR study von Agulnik, Jason Scott, Chouaid, Christos, Herder, Judith, Ziske, Carsten, Mitchell, Paul, Vansteenkiste, Johan F., Eriksson, Jennifer, Finnern, Henrik W., Lungershausen, Juliane, Lester, Jason

Volltext

LUX-Lung 6: Patient-reported outcomes (PROs) from a randomized open-label, phase III study in first-line advanced NSCLC patients (pts) harboring epidermal growth factor receptor (E... von Geater, Sarayut Lucien, Zhou, Caicun, Hu, Cheng-Ping, Feng, Ji Feng, Lu, Shun, Huang, Yunchao, Li, Wei, Hou, Mei, Shi, Jian Hua, Lee, Kye Young, Massey, Dan, Lungershausen, Juliane, Shi, Yang, Zazulina, Victoria, Wu, Yi Long

Volltext

Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial von HOOGENDOORN, Martine, AL, Maiwenn J, BEEH, Kai-Michael, BOWLES, David, GRAF VON DER SCHULENBURG, J. Matthias, LUNGERSHAUSEN, Juliane, MONZ, Brigitta U, SCHMIDT, Hendrik, VOGELMEIER, Claus, RUTTEN-VAN MÖLKEN, Maureen P. M. H

Volltext

Cost-Effectiveness of Strong Opioids Focussing on the Long-Term Effects of Opioid-Related Fractures: A Model Approach von Haß, Bastian, Lungershausen, Juliane, Hertel, Nadine, Nautrup, Barbara Poulsen, Kotowa, Wioletta, Liedgens, Hiltrud

Volltext

Does EGFR Mutation Type Influence Patient-Reported Outcomes in Patients with Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer? Analysis of Two Large, Phase III Studies Co... von Wu, Yi-Long, Hirsh, Vera, Sequist, Lecia V, Hu, Cheng-Ping, Feng, Jifeng, Lu, Shun, Huang, Yunchao, Schuler, Martin, Mok, Tony, Yamamoto, Nobuyuki, O’Byrne, Kenneth, Geater, Sarayut L, Zhou, Caicun, Massey, Dan, Märten, Angela, Lungershausen, Juliane, Yang, James Chih-Hsin

Volltext bestellen

The Economic Burden of Head and Neck Cancer: A Systematic Literature Review von Wissinger, Erika, Griebsch, Ingolf, Lungershausen, Juliane, Foster, Talia, Pashos, Chris L

Volltext